Tuesday, June 25, 2013

High court rules 'pay-for-delay' drug deals can face antitrust suits

In such deals, a drug maker agrees to pay a potential rival to delay selling a generic version. The decision may result in lower drug costs, advocates say.



WASHINGTON — A brand-name drug maker can be sued for violating antitrust laws if it agrees to pay a potential competitor to delay selling a generic version, the Supreme Court ruled.



via L.A. Times - Health http://feeds.latimes.com/~r/latimes/features/health/~3/OHc94b__plM/la-fi-court-generic-drugs-20130618,0,7238910.story

No comments:

Post a Comment